Karol Pawlina

The applicants brought a motion for a declaration that there were palpable errors in the assessment roll regarding the lot size of their property for the taxation years 2003 to 2013, and sought an extension of time to bring late appeals under s. 40.1 of the Assessment Act.

MPAC had incorrectly recorded the lot size as 7,405.2 sq. ft. larger than its actual size due to a 1963 calculation error.

The Assessment Review Board dismissed the motion, finding that the error was not 'palpable' because it was not plain and obvious, having gone unnoticed by the owners and MPAC for decades.

Consequently, the statutory precondition for exercising discretion to allow late appeals was not met.

The plaintiffs brought a motion for certification of a class action against the manufacturers of Pradaxa, an anticoagulant drug.

The plaintiffs alleged that the defendants breached their duty to warn consumers and healthcare professionals about the lack of an antidote for the drug, which could lead to excessive bleeding.

The court dismissed the certification motion, finding that the plaintiffs failed to establish that the proposed common issues actually existed or could be answered in common across the class.

The court noted that the decision to prescribe an anticoagulant and the need for a reversal agent are highly patient-specific, and there was no basis in fact to conclude that the absence of an antidote posed a common and material risk across the class.